Table 2.
Low-risk and high-risk HLA alleles for HIV-1 superinfection.
| HLA allele | n (%) | HR (95% CI) | P | Allele frequency of study participantsa |
|---|---|---|---|---|
| Low-risk allele | ||||
| HLA-DRB1*11 | 24 (24.5) | 0.13 (0.00–1.03) | 0.054 | 0.128 |
| High-risk allele | ||||
| HLA-A*29 | 10 (10.2) | 4.10 (0.88–14.76) | 0.069 | 0.051 |
| HLA-B*35 | 24 (24.5) | 4.64 (1.33–18.17) | 0.017 | 0.128 |
| HLA-C*04 | 26 (26.5) | 5.30 (1.51–20.77) | 0.010 | 0.153 |
| HLA-C*16 | 12 (12.2) | 4.05 (0.87–14.62) | 0.071 | 0.061 |
| HLA-DRB1*07 | 34 (34.7) | 3.29 (0.94–12.90) | 0.062 | 0.179 |
| HLA-DRB1*08 | 4 (4.1) | 15.37 (2.11–79.80) | 0.011 | 0.020 |
CI, confidence interval; HR, hazard ratio; n, number of individuals with a given allele.
a
Allele frequency in all 98 participating individuals.